TEVA bonds
Below is the list of TEVA corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
|---|---|---|---|---|---|---|---|---|---|
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 26.91% | 2 K | 85.00% | 0.25% | 2026-02-01 | 22.88 M USD | 1,000.00 USD | 1,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTFACTEVA P.FI.NL III 16/46 | 8.00% | 0 | 69.28% | 4.10% | 2046-10-01 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 6.96% | 1 M | 99.25% | 6.75% | 2028-03-01 | 255 K USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88163VAD1TEVA PHARM.FIN. 2036 | 6.24% | 0 | 99.44% | 6.15% | 2036-02-01 | 789.43 M USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTFABTEVA P.FI.NL III 16/26 | 5.79% | 0 | 96.83% | 3.15% | 2026-10-01 | 1.8 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA6082388Teva Pharmaceutical Finance Netherlands III BV 6.0% 01-DEC-2032 | 5.78% | 2.49 M | 101.13% | 6.00% | 2032-12-01 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| CCH33382750TEVA PH.FI.NL IV 16-25 | 5.77% | 0 | 99.48% | 1.00% | 2025-07-28 | 350 M CHF | 5,000.00 CHF | 5,000.00 CHF | Teva Pharmaceutical Finance Netherlands IV BV |
| TTEVA6082389Teva Pharmaceutical Finance Netherlands IV BV 5.75% 01-DEC-2030 | 5.58% | 3 M | 100.70% | 5.75% | 2030-12-01 | 700 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands IV BV |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5.52% | 1.2 M | 112.13% | 8.13% | 2031-09-15 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5.50% | 276 K | 102.95% | 6.75% | 2028-03-01 | 1.25 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5.47% | 500 K | 108.30% | 7.88% | 2029-09-15 | 397.68 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295245Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029 | 5.28% | 1.04 M | 99.50% | 5.13% | 2029-05-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295244Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027 | 5.25% | 609 K | 99.14% | 4.75% | 2027-05-09 | 649.12 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS308179796TEV.P.F.N.II 25/31 | 4.06% | 0 | 100.29% | 4.13% | 2031-06-01 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280419TEV.P.F.N.II 23/31 | 3.99% | 0 | 119.43% | 7.88% | 2031-09-15 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717TEV.P.F.N.II 21/30 | 3.92% | 0 | 101.88% | 4.38% | 2030-05-09 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443TEV.P.F.N.II 23/29 | 3.69% | 0 | 113.53% | 7.38% | 2029-09-15 | 662.58 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS143974936TEVA PH.F.NL.II 16/28 | 3.51% | 0 | 94.39% | 1.63% | 2028-10-15 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709TEV.P.F.N.II 21/27 | 3.50% | 0 | 100.44% | 3.75% | 2027-05-09 | 1.1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS121104407TEVA PH.F.NL.II 15/27 | 3.46% | 0 | 97.34% | 1.88% | 2027-03-31 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |